+
Site Tour

Search

Showing 21 - 30 of 427 results.

  • Overview

    Two Types of Mitral Regurgitation 1-YEAR MORTALITY UP TO 57%* Mitral regurgitation, if left untreated, initiates a ca
  • Diagnosis

    MR is a progressive disease, and patients may remain asymptomatic even when the condition has become severe, as compensatory mechanisms develop.11 In some cases, the following symptoms may be experi
  • Overview

    See Diagnosis AS is a progressive disease. While patients with AS may initially be asymptomatic, further progression is typically associated with symptoms and poor prognosis.13,14 AS is associa
  • Diagnosis

    The three cardinal symptoms of AS are angina, syncope or heart failure (HF).13,16 Other symptoms include dyspnea and decreased exercise tolerance.14 Primary care physicians should consider AS in ad
  • Options

    Treatment options for aortic stenosis: MEDICAL MANAGEMENT Medical treatment options for symptomatic patients with severe AS are limited. Medical treatment may be helpful in ameliorating symptoms in
  • Overview

    Secondary TR arising from RV remodelling can be classified in three progressive stages26 Initial Right Ventricular (RV) dilatation results in Tricuspid Annulus (TA) dilatation Progressive RV and
  • Case Study Library

    © Abbott 2023. All rights reserved. 9-EH-5-14377-01 07-2023
  • Recommendations

    STUDY DEMONSTRATING CASE FOR EARLY DEVICE INTERVENTION LEARN MORE INCREASED EXPERIENCE LEADS TO A MODIFIED PDA CLOSURE TECHNIQUE LEARN MORE FIND OUT MORE: Amplatzer Piccolo™ Clinical Trial
  • ABBOTT AT ESC 2024

    Watch R. S. von Bardeleben & E. Donal giving their perspective. R. S. von Bardeleben E. Donal RESHAPE-HF2 A second randomised clinical trial for MitraClip™ Transcatheter Edge-to-Edge Repai
  • LAAO Summit 2024

    ON DEMAND - LAAO SUMMIT 2024 13th International Left Atrial Appendage Occlusion Summit SESSION 1: DRT SESSION 2: LIVE SESSION 3: LEAK SESSION 4: LIVE SESSION 4: IMAGING & ANATOMY SESSION 4:

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline